National Inferior Vena Cava (IVC) Filter Registry
IVC Filter Study to Monitor and Measure Patients Outcomes Through Standardized Collection and Analysis of Clinical Information
1 other identifier
observational
20,000
1 country
27
Brief Summary
Inferior vena cava (IVC) filter is an important therapeutic device used in the management of venous thrombo-embolism (VTE) in patients that are contra-indicated for anti-coagulation therapy. While there has been significant increase in the use of filters , unfortunately there are no standardized collection of data to track, compare outcomes, report safety and efficacy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2011
Typical duration for all trials
27 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2011
CompletedFirst Submitted
Initial submission to the registry
June 3, 2011
CompletedFirst Posted
Study publicly available on registry
June 7, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2014
CompletedJune 21, 2013
June 1, 2013
1.9 years
June 3, 2011
June 20, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Integrity of IVC Filter 12 months post placement
48 Months
Eligibility Criteria
No specific criteria. Data from anyone who underwent IVC Filter Placement/Retrieval will be eligible
You may qualify if:
- Data obtained in line with good clinical practice,applicable laws and regulation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (27)
Exempla Lutheran Medical Center
Denver, Colorado, 80211, United States
University of Florida , Division of Vascular Surgery & Endovascular Therapy
Gainesville, Florida, 32610, United States
Bayfront Medical Center
St. Petersburg, Florida, 33701, United States
Medical Center of Central Georgia
Macon, Georgia, 31201, United States
Eastern Idaho Regional Medical Center
Idaho Falls, Idaho, 83401, United States
University of Chicago Hospitals
Chicago, Illinois, 60637, United States
Southern Illinois University School of Medicine
Springfield, Illinois, 62794, United States
University Of Kentucky , Vascular and Endovascular Divison
Lexington, Kentucky, 40506, United States
Tuoro Infirmary
New Orleans, Louisiana, 70115, United States
University Of Michigan Health System
Ann Arbor, Michigan, 48109-5867, United States
St. Luke's Medical Center
Chesterfield, Missouri, 63017, United States
St Peters Hospital
Helena, Montana, 59601, United States
Brooklyn Hospital
New York, New York, 11201, United States
University Of Rochester Medical Center
Rochester, New York, 14642, United States
Stony Brook University Medical Center, Vein Clinic
Stony Brook, New York, 11794, United States
Good Samaritan Hospital
Cincinnati, Ohio, 45220, United States
Jobst Vascular Institute
Toledo, Ohio, 43601, United States
Doylestown Hospital
Doylestown, Pennsylvania, 18901, United States
Lancaster General Hospital
Lancaster, Pennsylvania, 17601, United States
University of Pittsburgh School of Medicine Division of Vascular Surgery
Pittsburgh, Pennsylvania, 15213, United States
Palmetto Health and Providence Hospital
Columbia, South Carolina, 29201, United States
Vascular Health Alliance, Greenville Hospital System
Greenville, South Carolina, 29605, United States
Avera Sacred Heart Hospital
Yankton, South Dakota, 57078, United States
Northwest Texas Hospital
Amarillo, Texas, 79106, United States
University of Texas Medical Branch
Galveston, Texas, 77555, United States
Intermountain Medical Center
Murray, Utah, 84157, United States
West Virginia University Healthcare
Morgantown, West Virginia, 26505, United States
Related Links
Study Officials
- STUDY CHAIR
Brajesh K Lal
University of Maryland Medical Center,Baltimore
- PRINCIPAL INVESTIGATOR
John E. Rectenwald
University of Michigan
- STUDY DIRECTOR
Uchenna N Onyeachom
American Venous Forum
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 3, 2011
First Posted
June 7, 2011
Study Start
May 1, 2011
Primary Completion
April 1, 2013
Study Completion
May 1, 2014
Last Updated
June 21, 2013
Record last verified: 2013-06